Mindset Pharma Inc
CNSX:MSET
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CA |
M
|
Mindset Pharma Inc
CNSX:MSET
|
60.8m CAD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD |
Loading...
|
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
525.7B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
277B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
210.3B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
220.9B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
271.6B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.8T DKK |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
148.4B USD |
Loading...
|
Market Distribution
| Min | -4 710 029.9% |
| 30th Percentile | -65.8% |
| Median | -2.4% |
| 70th Percentile | 11% |
| Max | 71 100% |
Other Profitability Ratios
Mindset Pharma Inc
Glance View
Mindset Pharma, Inc. is a pharmaceutical discovery and development company. The company is headquartered in Toronto, Ontario. The company went IPO on 2020-12-23. The firm is focused on developing patentable psychedelic compounds for the treatment of neurological and psychiatric disorders, with an initial focus on psilocybin-inspired new chemical entities (NCEs). Its drug development platform seeks to advance medicines based on psychedelic substances through rigorous scientific and clinical trials, performed by third-party contract research organizations. The firm intends to commercialize the psilocybin-inspired psychedelic medicines that it develops as regulated medicines.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Mindset Pharma Inc is -90.9%, which is below its 3-year median of -76.2%.
Over the last 1 years, Mindset Pharma Inc’s Operating Margin has increased from -873.6% to -90.9%. During this period, it reached a low of -873.6% on Mar 31, 2022 and a high of -61.5% on Dec 31, 2022.